Immunopharmacological studies on the anti-allergic actions of traditional Chinese medicines and related components

Journal of Traditional Medicines

Volumn 21, Issue 5, 2004, Pages 205-214

  Nagai, Hiroichi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

allergic inflammation; allergy; anti allergic drug; IgE; traditional Chinese medicine

Indexed keywords

EID: 85009630397     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.21.205     Document Type: Article

References (74)

1. Labelle, M., Beaulieu, M., Renzi, P., Rahme, E., Thivierge, RL.: Integrating clinical practice guidelines into daily practice: impact of an interactive workshop on drafting of a written action plan for asthma patients. J. Contin. Educ. Health. Prof. 24, 39-40, 2004.
2. Reed, CE.: Inhaled corticosteroids: why do physicians and patients fail to comply with guidelines for managing asthma? Mayo. Clin. Proo. 79, 453, 2004.
3. American Thoracic Society.: Guidelines for assessing and managing asthma risk at work, school, and recreation. Am. J. Respir. Crit. Caro. Med. 169, 873, 2004.
4. Valovirta, E., Passalacqua, G., Canonica, WG.: Non-injection routes for immunotherapy of allergic diseases. Clin. Allergy. Immunol. 18, 607-623, 2004.
5. Oermann, MH., Gerich, J., Ostosh, L., Zaleski, S.: Evaluation of asthma websites for patient and parent education. J. Pediatr. Nurs. 18, 389-396, 2003.
6. Haitchi, HM., Holgate, ST.: New strategies in the treatment and prevention of allergic diseases. Expert. Opin. Investig. Drugs. 13, 107-124, 2004.
7. Bousquet, J., Michel, FB., Vignola, AM.: Allergen immunotherapy: therapeutic vaccines for asthma. Clin. Allergy. Immunol. 18, 511-528, 2004.
8. Rosado-Printo, J., Morais-Almeida, M.: Asthma in developing worlds. Padiatr. Pulmonol. Suppl. 26, 66-68, 2004.
9. Tilg, H., Käser, A.: Type I interferons and their therapeutic role in Th2-reguiated inflammatory disorders. Expert. Opin. Biol. Ther. 4, 400-431, 2004.
10. Orhan, F., Sekerel, BE., Adalioglu, G., Pinar M., Tuncer, A.: Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis. Ann. Allergy. Asthma. Immunol. 92, 438-445, 2004.
11. Holgate, ST.: Airway inflammation and remodeling in asthma: current concepts. Mol. Biolechnol. 22, 179-189, 2002.
12. Brightling, CE., Bradding, P., Symon, FA., Holgate, ST., Wardlaw, AJ., Pavord, ID.: Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346, 1699-1705, 2002.
13. Persiani, S., D'Amato, M., Makovec, F., Arshad, SH., Holgate, ST., Rovati, LC.: Pharmacokinetics of andolast after administrating of single escalating doses by inhalation in mild asthmatic patients. Biopharm. Drug. Dispos. 22, 73-81, 2001.
14. Reisman, RE. : Guidelines for management of people with histories of insect sting anaphylaxis and subsequent negative venom skin tests. J. Allergy. Clin. Immunol. 113, 364, 2004.
15. Clark, S., Bock, SA., Gaeta, TJ., Brenner, BE., Cydulka, RK., Camargo, CA; Multicenter Airway Research Collaboration-8 Investigators.: Multicenter study of emergency department visit for food allergies. J. Allergy. Clin. Immunol. 113, 347-352, 2004.
16. Crocetti, MT., Barone, MA., Amin, DD., Walker, AR.: Pediatric observation status beds on an inpatient unit: an integrated care model. Pediatr. Emerg. Care. 20, 17-21, 2004.
17. Whitehead, N.: Herbal remedies: integration into conventional medicine. Nurs. Times. 99, 30-33, 2003.
18. Cretin, S., Farley, DO., Dolter, KJ., Nicholas, W.: Evaluating an integrated approach to clinical quality improvement: clinical guidelines, quality measurement, and supportive system design. Med. Care. 39, 70-84, 2001.
19. Standish, LJ., Greene, KB., Bain, S., Reeves, C., Sanders, F., Wines, RC., Turet, P., Kim, JG., Calabrese, C.: Alternative medicine use in HIV-positive men and women: demographics, utilization patterns and health status. AIDS. Care. 13, 197-208, 2001.
20. Ziment, I., Tashkin, DP.: Alternative medicine for allergy and asthma. J. Allergy. Clin. Immunol. 106, 603-614, 2000.
21. Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., Eguchi, N., Urade, Y., Yoshida, N., Kimura, K., Mizoguchi, A., Honda, Y., Nagai, H., Narumiya, S.: Prostaglandin D2 as a mediator of allergic asthma. Science 287, 2013-2017, 2000.
22. Takahashi, Y., Tokuoka, S., Masuda, T., Hirano, Y., Nagao, M., Tanaka, H., Inagaki, N., Narumiya, S., Nagai, H.: Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 137, 315-322, 2002.
23. Nagao, K., Tanaka, H., Komai, M., Masuda, T., Narumiya, S., Nagai, H.: Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am. J. Respir. Cell. Mol. Biol. 29, 314-320, 2003.
24. Kabashima, K., Murata, T., Tanaka, H., Matsuoka, T., Sakata, D., Yoshida, N., Katagiri, K., Kinashi, T., Tanaka, T., Miyasaka, M., Nagai, H., Ushikubi, F., Narumiya, S.: Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4, 694-701, 2003.
25. Nagai, H., Yamaguchi, S., Inagaki, N., Tsuruoka, N., Hitoshi, Y., Takatsu, K.: Effect of anti-IL-5 monoclonal antibody on allergic bronchial eosinophilia and airway hyperresponsiveness in mice. Life. Sci. 53, PL243-247, 1993.
26. Nagai, H., Ueda, Y., Tanaka, H., Hirano, Y., Nakamura, N., Inagaki, N., Takatsu, K., Kawada, K.: Effect of overproduction of interleukin 5 on dinitrofluorobenzene-induced allergic cutaneous response in mice. J. Pharmacol. Exp. Ther. 288, 43-50, 1999.
27. Tanaka, H., Kawada, N., Yamada, T., Kawada, K., Takatsu, K., Nagai, H.: Allergen-induced airway inflammation and bronchial responsiveness in interleukin-5 receptor alpha chain-deficient mice. Clin. Exp. Allergy. 30, 874-881, 2000.
28. Tanaka, H., Komai, M., Nagao, K., Ishizaki, M., Kajiwara, D., Takatsu, K., Delespesse, G., Nagai, H.: Role of IL-5 and eosinophils in allergen-induced airway remodeling in mice. Am. J. Respir. Cell. Mol. Biol. 19, Epub ahead of print, 2004.
29. Masuda, T., Tanaka, H., Komai, M., Nagao, K., Ishizaki, M., Kajiwara, D., Nagai, H.: Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma. Clin. Exp. Allergy. 33, 705-713, 2003.
30. Komai, M., Tanaka, H., Masuda, T., Nagao, K., Ishizaki, M., Sawada, M., Nagai, H.: Role of Th2 responses in the development of allergic asthma. Br. J. Pharmacol. 138, 912-920, 2003.
31. Koda, A., Nishiyori, K., Nagai, H., Matsuura, N., Tsuchiya, H.: Anti-allergic actions of crude drugs and blended Chinese traditional medicines: Effect on type Iand IV allergic reactions. Folia. Pharmacol. Japan. 80, 31-41, 1982.
32. Koda, A., Nagai, H., Wada, H.: Pharmacological actions of baicalin and baicalein. 1. On active anaphylaxais. Folia. Pharmacol. Japan. 66, 194-213, 1970.
33. Koda, A., Nagai, H., Wada, H.: Pharmacological actions of baicalin and baicalein. 2. On passive anaphylaxis. Folia. Pharmacol. Japan. 66, 237-247, 1970.
34. Koda, A., Nagai, H., Yoshida, Y., Lauw, HK.: Pharmacological actions of baicalin and baicalein. 3. Action on experimental asthma. Folia. Pharmacol. Jagan. 66, 471-486, 1970.
35. Nagai, H., Osuga, K., Koda, A.: Inhibition of hypersensitivity reactions by soluble derivatives of baicalein. Jpn. J. Pharmacol. 25, 763-772, 1975.
36. Koda, A., Watanabe, S., Yanagihara, Y., Nagai, H., Sakamoto, K.: A comparative study of the anti-allergic effects of disodium baicalein 6-phosphate (BPS) and disodium cromoglycate (DSCG). Jpn. J. Pharmacol. 27, 31-38, 1977.
37. Koda, A., Nagai, H., Watanabe, S., Kiat, LH., Katayama, S.: On the combined effect of Scutellaria Baicaleinsis Georgi and anti-asthmatic drugs. Arerugi 21, 346-359, 1972.
38. Koda, A., Nagai, H., Watanabe, S., Yanagihara, Y., Sakamoto, K.: Inhibition of hypersensitivity reactions by a new drug, N (3;4′-dimethoxyannamoyl) anthranilic acid(N-5′). J. Allergy. Clin. Immunol. 57, 396-407, 1976.
39. Nagai, H., Kelly, K., Sehon, AH. : The inhibition of histamine release by anti-allergic drugs. Int. Archs. Allergy. appe. Immunol. 56, 307-315, 1078.
40. Koda, A., Nagai, H., Katayama, S., Inoue, K., Nakamura, K.: Experimental asthma in rats and the effects of tranilast. Folia. Pharmacol. Japan. 74, 699-709, 1978.
41. Tominaga, T., Watanabe A., Tsuji, J., Koda, A., Nagai, H., Kumazawa, Y., Shimada, H.: Effect of TYB-2285 on antigen- induced accumulation of eosinophils into the peritoneal cavity of rats sensitized with Ascaris suum extract. Gen. Pharmacol. 28, 411-414, 1997.
42. Mori, H., Tanaka, H., Kawada, K., Nagai, H., Koda, A. : Suppressive effects of tranilast on pulmonary fibrosis and activation of alveolar macrophages in mice treated with bleomycin: role of alveolar macrophages in the fibrosis. Jon. J. Pharmacol. 67, 279-289, 1995.
43. Nagai, H., Sakurai, T., Inagaki, N., Mori, H.: An immunopharmacological study of the biphasic allergic skin reaction in mice. Biol. Pharm. Bull. 18, 239-245, 1995.
44. Nagai, H., Tsuji, F., Goto, S., Koda, A.: Pharmacological study of bacterial lipopolvsaccharide-induced airway hyperresponsiveness in guinea pigs. Arch. Int. Pharmacodyn. ther. 313, 161-175, 1991.
45. Nagakura, T., Iikura, Y., Onda, T., Masaki, T., Endo, T., Nagakura, H., Nagai, H.: Release of high-molecular-weight neutrophil chemotactic activity from resected human nasal turbinate after antigen challenge. J. Allergy. Clin. Immunol. 83, 656-662, 1989.
46. Inagaki, N., Nagai, H., Xu, QA., Daikoku, M., Nakatomi, I., Koda, A.: Effects of different drugs on passive cutaneous anaphylaxis elicited in the mouse ear at 1.5 hours. Int. Arch. Allergy. Appl. Immunol. 86, 157-161, 1988.
47. Nagai, H., Yakuo, I., Togawa, M., Arimura, A., Matsuura, N., Koda, A., Hamano, S., Ujiie, A., Nakazawa, M.: Effect of OKY-046, a new thromboxane A2 synthetase inhibitor, on experimental asthma in guinea pigs. Prostaglandins. Leukot. Med. 30, 111-121, 1987.
48. Nagai, H., Yamada, H., Yakuo, I., Inagaki, N., Choi, SH., Koda, A., Daikoku, M.: Effect of cinnarizine on IgE antibody-mediated experimental allergic reactions in guinea pigs. Allergy 42, 135-140, 1987.
49. Nagai, H., Yamada, H., Matsuura, N., Iwamoto, T., Choi, SH., Koda, A.: Pharmacological studies on the release of slow reacting substance of anaphylaxis during anti-immunoglobulin E antibody mediated passive peritoneal anaphylaxis in rats. J. Pharmacobiodyn. 10, 49-54, 1987.
50. Nagai, H., Yakuo, I., Yamada, H., Inagaki, N., Goto, S., Koda, A.: Effect of cinnarizine on IgE antibody mediated allergic reaction in mice and rats. J. Pharmacobiodyn. 9, 923-927, 1986.
51. Mori, H., Fuchigami, M., Inoue, N., Nagai, H., Koda, A., Nishioka, I., Meguro, K.: Principle of the bark of Phellodendron amurense to suppress the cellular immune response: effect of phellodendrin on cellular and humoral immune renponses. Planta. Med. 61, 45-49, 1995.
52. Mori, H., Fuchigami, M., Inoue, N., Nagai, H., Koda, A., Nishioka, I.: Principle of the bark of Phellodendron amurense to suppress the cellular immune response. Planta. Med. 60, 445-449, 1994.
53. Nagai, H., Shimazawa, T., Matsuura, N., Koda, A.: Immunopharmacological studies on the aqueous extract of Cinnamomum Cassia (CCAq) I. Anti-allergic action. Japan. J. Pharmacol. 32, 813-822, 1982.
54. Nagai, H., Shimazawa, T., Takizawa, T., Koda, A., Yagi, A., Nishioka, I.: Immunopharmacological studies on the aqueous extract of Cinnemomum Cassia (CCAq) II. Effect of CCAq on experimental glomezulonephritis. Japan. J. Pharmacol. 32, 823-831, 1982.
55. Yagi, A., Nohara, T., Nishioka, I., Koda, A., Nagai, H.: Chemical studies on aqueous extract 8 Cinnamomi cortex and its therapeutic examination for experimental nephritis. Proc. Symp-WAKAN-YAKU. 13, 72-78, 1980.
56. Nagai, H., Yakuo, I., Aoki, M., Teshima, K., Ono, Y., Sengoku, T., Shimazawa, T., Abutada, M., Koda, A.: The effect of Gomisin A on Immunologic Liver Injury in mice. Planta. Med. 55, 13-17, 1989.
57. Nagai, H., Nishiyori, T., Ochi, T., Imai, Y., Tanaka, H., Inagaki, N.: The effect of methanolic extract from Corydalis Tuber on cytokine production and allergic reactions in experimental animals. J. Trad. Med. 16, 51-57, 1999.
58. Shichijo, M., Yamamoto, N., Tsujishita, H., Kimata, M., Nagai, H., Kokubo, T.: Inhibition of syk activity and degranulation of human mast cells by flavonoids. Biol. Pharm. Bull. 26, 1685-1690, 2003.
59. Kimata, M., Inagaki, N., Kato, T., Miura, T., Serizawa, I., Nagai, H.: Role of mitogen-activated protein kinase pathways for mediator release from human cultured mast cells. Biochem Pharmacol. 60, 589-594, 2000.
60. Kimata, M., Shichijo, M., Miura, T., Serizawa, I., Inagaki, N., Nagai, H.: Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin. Exp. Allergy. 30, 501-508, 2000.
61. Kimata, M., Inagaki, N., Nagai, H.: Effects of luteolin and other flavonoids on IgE-mediated allergic reactions. Planta. Med. 66, 25-29, 2000.
62. Kimata, M., Shichijo, M., Miura, T., Serizawa, I., Inagaki, N., Nagai, H.: Ca2+ and protein kinase C signaling for histamine and sulfidoleukotrienes released from human cultured mast cells. Biochem. Biophys. Res. Commun. 257, 895-900, 1999.
63. Nishiyori, T., Tsuchiya, H., Inagaki, N., Nagai, H., Koda, A.: Effect of Saiboku-to, a blended Chinese traditional medicine, on Type I hypersensitivity reactions, particularly on experimentally-caused asthma. Folia. Pharmacol. Japan. 85, 7-16, 1985.
64. Nishiyori, T., Nakatami, I., Matsuura, N., Nagai, H., Koda, A.: Effect of Chinese blended medicine, Saiboku-to, on type IV allergic reaction. Arerugi 32, 317-323, 1983.
65. Koda, A., Nishiyori, T., Nagai, H., Matsuura, N., Tsuchiya, H.: Anti-allergic actions of traditional oriental medicine-actions against types I and IV hypersensitivity reactions. Folia. Pharmacol. Japan. 80, 31-41, 1982.
66. Koda, A., Ono, Y., Nishiyori, T., Nagai, H., Matsuura, N., Mase, A., Matsuyama, T.: Immunopharmacological studies of wen-qing-yin, a Chinese blended medicine: effects on type IV allergic reactions and humoral antibody production. Int. J. Immunopharmacol. 9, 289-295, 1987.
67. Nagai, H., Takedoi, H., Nishiyori, T., Ochi, T., Sawada, M., Kato, T., Inagaki, N., Morita, M., Komatsu, Y.: Effect of sho-sei-ryu-to on experimental allergic reactions. J. Trad. Med. 17, 49-58, 2000.
68. Tahara, E., Sato, T., Watanabe, C., Nagai, H., Shimada, Y., Terasawa, K., Saiki, I.: Effext of Kampo medicines on IgE mediated biphasic cutaneous reaction in mice. J. Trad. Med. 15, 100-108, 1998.
69. Tsunematsu, M., Nakai, N., Inagaki, N., Nagai, H.: Effect od shoufu-san on ecperimental allergic cutaneous reaction. J. Trad. Med. 13, 66-72, 1996.
70. Nagai, H., Nakai, N., Nishiyori, T., Ogiso, H., Ochi, T., Tanaka, H., Inagaki, N.: Effect of Byakko-ka-ninjin-to on experimental allergic cutaneous reaction. J. Trad. Med. 15, 208-215, 1998.
71. Tatsumi, T., Yamada, T., Nagai, H., Terasawa, K., Tani, T., Nunome, S., Saiki, I.: A Kampo Formulation: Byakko-ka-ninjin-to inhibits IgE-mediated Triphasec skin reaction in mice: The role of its constituents in expression of the efficacy. Biol. Pharm. Bull. 24, 284-290, 2001.
72. Tahara, E., Satoh, T., Toriizuka, K., Nagai, H., Nunome, S., Shimada, Y., Itoh, T., Terasawa, K., Saiki, I.: Effect of Shimatsu-to and its constituents on triphasic skin reaction in passively sensitized mice. J. Ethnopharm. 68, 219-228, 1999.
73. Yamada, T., Tahara, E., Nagai, H., Terasawa, K., Tani, T., Nunome, S., Saiki, I.: Effect of some Kampo medicines, including Tokaku-joki-to on IgE-mediated triphasic skin reaction in passively sensitized mice. J. Trad. Med. 17, 17-25, 2000.
74. Tahara, E., Wu, W., Satoh, T., Yamada, T., Kurosaki, I., Nagai, H., Nunome, S., Terasawa, K., Saiki, I.: Psychosocial stress enhances IgE-mediated triphasic cutaneous reaction in mice: antagonism by Yokukan-san and diazepam. Allergol. Int. 50, 211-222, 2001.